Britain granted conditional authorization on Thursday to the first pill shown to successfully treat COVID-19 so far. It also is the first country to OK the treatment from drugmaker Merck, although it wasn’t immediately clear how quickly the pill would…
Read More
Developing antiviral drugs is not easy—here’s why
The UK prime minister, Boris Johnson, recently announced the creation of an antivirus taskforce to “supercharge” the development of new antiviral drugs. At a Downing Street press conference, Johnson said: “The majority of scientific opinion in this country is still…
Read More
IDSA Updates COVID-19 Treatment Guidelines: Monoclonals and More
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. While there is still no “game-changer” for treating COVID-19, the Infectious Diseases Society of America (IDSA) continues to examine available and potential treatments as new evidence…
Read More
Malaria discovery could expedite antiviral treatment for COVID-19
The study, conducted by an international team and led by RMIT University’s Professor Christian Doerig, outlines a strategy that could save years of drug discovery research and millions of dollars in drug development by repurposing existing treatments designed for other…
Read More
Flu researchers say we should make a NEW antiviral to stop coronavirus
Flu researchers say we should make a NEW antiviral to prevent coronavirus from replicating throughout the body and stop focusing on repurposing old drugs Researchers looked an older treatment for the flu, Tamiflu, and a newer treatment, Xofluza, the first…
Read More
‘In a crisis like this, an antiviral drug could buy us some time’
Francesco Stellacci, a professor in EPFL’s School of Engineering, discusses his research in the field of nanomedicine and how it could help us get past the coronavirus crisis. As the COVID-19 outbreak rages on, researchers are in a race against…
Read More